Naoto T. Ueno
Corresponding Authors: Naoto T. Ueno
Department of Breast Medical Oncology
Unit 1354
University of Texas MD Anderson Cancer Center
Name/email consistency: high
- MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15-Dependent Manner in a Mouse Xenograft Model. Bartholomeusz, C., Oishi, T., Saso, H., Akar, U., Liu, P., Kondo, K., Kazansky, A., Krishnamurthy, S., Lee, J., Esteva, F.J., Kigawa, J., Ueno, N.T. Mol. Cancer Ther. (2012)
- Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients. Cheng, Y.C., Takagi, M., Milbourne, A., Champlin, R.E., Ueno, N.T. Oncologist (2012)
- Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer. Niikura, N., Liu, J., Costelloe, C.M., Palla, S.L., Madewell, J.E., Hayashi, N., Yu, T.K., Tokuda, Y., Theriault, R.L., Hortobagyi, G.N., Ueno, N.T. Oncologist (2011)
- Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer. Hayashi, N., Iwamoto, T., Gonzalez-Angulo, A.M., Ferrer-Lozano, J., Lluch, A., Niikura, N., Bartholomeusz, C., Nakamura, S., Hortobagyi, G.N., Ueno, N.T. Oncologist (2011)
- Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer. Ueno, N.T., de Souza, J.A., Booser, D., Nakayama, K., Madewell, J., Wendt, R.E., Hortobagyi, G.N., Podoloff, D., Champlin, R.E. Clin. Breast Cancer (2009)
- What's past is prologue: lessons learned and the need for further development of allogeneic hematopoietic stem cell transplantation for renal cell carcinoma. Ueno, N.T., Childs, R.W. Biol. Blood Marrow Transplant. (2007)
- High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy. Ueno, N.T., Konoplev, S., Buchholz, T.A., Smith, T., Rondón, G., Anderlini, P., Giralt, S.A., Gajewski, J.L., Donato, M.L., Cristofanilli, M., Champlin, R.E. Bone Marrow Transplant. (2006)
- Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Ueno, N.T., Cheng, Y.C., Rondón, G., Tannir, N.M., Gajewski, J.L., Couriel, D.R., Hosing, C., de Lima, M.J., Anderlini, P., Khouri, I.F., Booser, D.J., Hortobagyi, G.N., Pagliaro, L.C., Jonasch, E., Giralt, S.A., Champlin, R.E. Blood (2003)
- Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Ueno, N.T., Anagnostopoulos, A., Rondón, G., Champlin, R.E., Mikhailova, N., Pankratova, O.S., Zoubarovskaya, L.S., Semenova, E.V., Afanasyev, B.V., O'Brien, S., Andreeff, M., Zaritskey, A.Y. Br. J. Haematol. (2002)
- E1A: tumor suppressor or oncogene? Preclinical and clinical investigations of E1A gene therapy. Ueno, N.T., Yu, D., Hung, M.C. Breast. Cancer (2001)









